Akebia flags late-breaking ASN Kidney Week presentation of VOICE trial results for vadadustat in hemodialysis anemia

AKBA•2026-10-06

Akebia said U.S. Renal Care will present VOICE trial results on October 23 at ASN Kidney Week 2026, comparing three-times-weekly vadadustat with an ESA for hemodialysis anemia.

1. VOICE trial presentation

Akebia flagged clinical updates at ASN Kidney Week 2026 in Denver, scheduled for October 21-25. U.S. Renal Care will present VOICE trial results on October 23, focusing on safety outcomes from a comparison of three-times-weekly vadadustat with an ESA in hemodialysis anemia.

2. Other study posters

Conference posters will also outline Phase 2 work on praliciguat in FSGS and a Phase 2 basket trial of ebribafusp alfa.

Akebia flags late-breaking ASN Kidney Week presentation of VOICE trial results for vadadustat in hemodialysis anemia

1. VOICE trial presentation

2. Other study posters

Related News

McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal

PTC Inc.: Oppenheimer cuts to Perform from Outperform

Uber to buy US catering platform ezCater for $2.3 billion

Runway Growth Finance sets third-quarter 2026 results release and conference call

Lincoln National Corp: UBS raises target price to $46 from $44